Related Experiment Video

Updated: May 10, 2026

Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

Total lipid management and cardiovascular disease in the dyslipidemia international study

Jean Ferrières1, Vian Amber, Oliviu Crisan

  • 1Department of Cardiology, Toulouse Rangueil University Hospital, Toulouse, France. jean.ferrieres@univ-tlse3.fr

Cardiology
|June 6, 2013
PubMed

Insights

Many cardiovascular disease patients on statins still have abnormal lipid levels, indicating a need for improved management. Peripheral artery disease patients particularly require better lipid control to achieve treatment goals.

Area of Science:

  • Cardiology
  • Lipidology
  • Public Health

Background:

  • Cardiovascular disease (CVD) management often involves statin therapy to control lipid levels.
  • Despite widespread statin use, a significant portion of patients do not achieve target lipid profiles.
  • Residual lipid abnormalities contribute to ongoing cardiovascular risk.

Purpose of the Study:

  • To estimate the prevalence of residual lipid abnormalities in patients with CVD receiving statin therapy.
  • To assess the adequacy of current lipid management strategies in this population.
  • To identify patient subgroups that may benefit from intensified lipid-lowering interventions.

Main Methods:

  • An international observational study involving 11,104 patients with atherosclerotic CVD.
  • Patients included had at least 3 months of statin therapy.
  • Fasting plasma concentrations of LDL-C, HDL-C, and triglycerides were measured.

Main Results:

  • 41% and 46% of patients did not meet LDL-C and total cholesterol goals, respectively.
  • Patients with peripheral artery disease (PAD) showed higher rates of uncontrolled lipids (59% LDL-C, 65% total cholesterol).
  • Elevated LDL-C was the most common lipid anomaly; heart failure was associated with dyslipidemia.

Conclusions:

  • Approximately 40% of statin-treated CVD patients have suboptimal lipid levels or fail to reach treatment goals.
  • Patients with PAD represent a key group that could benefit from enhanced lipid management strategies.
  • Future approaches should consider targeting not only LDL-C but also HDL-C and triglycerides for comprehensive CVD risk reduction.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...